Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials.
From Meridian Bioscience, Inc.Sep 18 2023 Meridian Bioscience, Inc., a leading global provider of diagnostic testing solutions and life science raw materials, announced today that the United States Food and Drug Administration has cleared Premier® HpSA® FLEX™ for the diagnosis of H. pylori in both preserved and unpreserved stools. Premier HpSA Flex joins the extensive Meridian H.
Meridian strives to continuously improve existing products. The Premier HpSA FLEX workflow improvement recently cleared by FDA allows clinicians to use preserved stools in Cary-Blair and C&S in addition to fresh or frozen unpreserved samples. Meridian’s Premier HpSA FLEX test is a non-invasive enzyme immunoassay used to qualitatively detect Helicobacter pylori specific antigens in fresh, frozen, or preserved human fecal specimens.
“Meridian is committed to developing the industry’s broadest range of highly accurate Gastrointestinal diagnostic solutions enabling clinicians to use the sample types and testing platforms required in today’s ever-evolving healthcare landscape,” Tony adds, “H. pylori is found in the stomach lining of 1 in 3 people1 and, if left untreated, can lead to gastric cancer. However, once diagnosed, an H. pylori infection can be easily treated with antibiotics.
You can learn more about Meridian’s diagnostic testing solutions by visiting their exhibit booth during this year’s AACC conference held in July in Anaheim, California. You can schedule a one-on-one meeting with a Meridian representative by emailing [email protected]. To learn more about H. pylori and Meridian’s testing solutions, please visit www.meridianbioscience.com/hpylori.